Ion Beam Applications SA (EBR:IBAB)

Market Cap	452.67M +33.1%
Revenue (ttm)	620.18M +24.5%
Net Income	12.73M +37.6%
EPS	0.42 +33.9%
Shares Out	29.13M
PE Ratio	36.97
Forward PE	9.36
Dividend	0.25 (1.61%)
Ex-Dividend Date	Jun 18, 2025

Volume	23,111
Average Volume	30,636
Open	15.36
Previous Close	15.54
Day's Range	15.30 - 15.56
52-Week Range	9.90 - 15.90
Beta	1.19
RSI	64.45
Earnings Date	Apr 30, 2026

About Ion Beam Applications

Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments, serious illnesses, and industrial applications in Belgium, the United States, China, Germany, and India. It operates through four segments, Clinical Proton Therapy; Clinical Dosimetry; IBA Technologies; and IBA Corporate. The company develops ConformalFLASH, a novel technique using the proton Bragg peak; DynamicARC, a technique that allows dynamic spot scanning irradiation and energy switching while the gantry is rotating; Proteus ONE, a compa...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 2,100
• Stock Exchange: Euronext Brussels
• Ticker Symbol: IBAB

Financial Performance

In 2025, Ion Beam Applications's revenue was 620.18 million, an increase of 24.49% compared to the previous year's 498.16 million. Earnings were 12.73 million, an increase of 37.59%.